
Uppsala Reports editor
@UMCGlobalSafety
Photo: iStock
Drug Safety Matters dives into the fascinating field of pharmacogenomics and the implications it has for tailored treatments and safer prescribing practices.
Genetic variation is one of the reasons people differ in their response to medicines. Understanding that variation can inform more refined choices of drugs and doses – ultimately preventing undesired side effects. Join us as we discuss past, present and future of pharmacogenomics with Uppsala Monitoring Centre’s Qun-Ying Yue.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
Read more
Pharmacogenomics group aims to refine patient safety options
By utilising automated web reporting and a triage sorting system, the pharmacovigilance centre Lareb enabled near real-time processing of over 200 000 COVID-19 vaccine AEFI reports
Research / 27 March 2023
The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.
Research / 16 March 2023
Real-world data is a rich source of evidence for pharmacovigilance, but there are challenges yet to be faced before unlocking its true potential as a resource.
Research / 31 March 2023